arrow
A

Arvind Mathur

Bristol Myers Squibb
H指数:32
被引数:3,506

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Discovery of BMS-159; an Orally Active Imidazotriazine Pan-CK2 Inhibitor for the Treatment of Cancer

BMS-159的发现;一种口服活性的咪唑三嗪泛CK2抑制剂用于癌症治疗

2026-04-220
PRE
From Flat to 3D: Replacing Phenyl Rings with Saturated Bridged Bicyclic Mimetics to Mitigate Bioactivation and Optimize ADME Properties and Oral Bioavailability in Reverse Amide Orientation

从平面到3D:用饱和桥环双环拟肽取代苯环以降低生物活化并优化反向酰胺取向的ADME性质和口服生物利用度

2026-03-300
PRE
Desymmetrization of meso-Anhydride Enabled Enantioselective Synthesis of (−)-7-(Bromomethylene)-3-amidobicyclo[2.2.1]heptane-2-carboxamide; a Scaffold for Divergent Drug Discovery Synthesis

meso-酐的不对称破坏实现 (−)-7-(溴亚甲基)-3-氨基硫杂双环[2.2.1]庚烷-2-甲酰胺的对映选择性合成;一种用于发散式药物发现合成的骨架

2025-12-030
PRE
Beyond Bioisosteres: Impact of Replacing a Benzene Ring with sp3-Rich Three-Dimensional Saturated Bridged Bicyclic Match Pairs on Biotransformation; Metabolic Stability; and Other ADME Profiles

超越生物电子等排体:用sp3-富集的三维饱和桥环双环匹配对替换苯环对生物转化、代谢稳定性及其他ADME特性的影响

2025-10-010
PRE
Discovery of liver-selective glucokinase activators comprising N-(4-alkylthiazol-2-yl)benzamides and N-(3-alkyl-1,2,4-thiadiazol-5-yl) benzamides for the treatment of metabolic disorders

肝选择性葡萄糖激酶激活剂的发现,包括N-(4-烷基硫唑-2-基)苯甲酰胺和N-(3-烷基-1,2,4-噻二唑-5-基)苯甲酰胺,用于治疗代谢紊乱

2025-07-010
PRE
The Discovery of C7-Substituted Norbornyl Bisamides as RXFP1 Small Molecule Agonists

C7-取代降冰片基双酰胺类化合物作为RXFP1小分子激动剂的发现

2025-05-280
PRE
Discovery and Characterization of a First-in-Class LIV1-TLR7/8 Immunomodulatory Conjugate with Robust Myeloid Activation and Antitumor Activity

发现并表征了一种具有强效髓系细胞激活和抗肿瘤活性的首创LIV1-TLR7/8免疫调节偶联物

2025-05-240
OA
Structure-Based Design of Novel TLR7/8 Agonist Payloads Enabling an Immunomodulatory Conjugate Approach
2024-12-190
PRE
Atropisomerism Observed in Galactose-Based Monosaccharide Inhibitors of Galectin-3 Comprising 2-Methyl-4-phenyl-2,4-dihydro-3H-1,2,4-triazole-3-thione
2024-08-050
PRE
Discovery of BMS-986308: A Renal Outer Medullary Potassium Channel Inhibitor for the Treatment of Heart Failure
2024-05-292
PRE
Challenges with the Synthesis of a Macrocyclic Thioether Peptide: From Milligram to Multigram Using Solid Phase Peptide Synthesis (SPPS)
2024-04-234
PRE
Identification of benzothiazole derived monosaccharides as potent, selective, and orally bioavailable inhibitors of human and mouse galectin-3; a rare example of using a S⋅⋅⋅O binding interaction for drug design
2024-03-011
PRE
Identification and Optimization of Small Molecule Pyrazolopyrimidine TLR7 Agonists for Applications in Immuno-oncology
2024-01-092
PRE
Discovery of Novel TLR7 Agonists as Systemic Agent for Combination With aPD1 for Use in Immuno-oncology
2024-01-083
PRE